Publications
5891 Results
- Journal / Conference
- Translational Oncology 7(1):101-110;
- Year
- 2014
- Research Committee(s)
- Breast
- PMID
- PMID24772213
- PMC
- PMC3998680
- Study Number(s)
- S0800
Image registration for quantitative parametric response mapping of cancer treatment response
- Journal / Conference
- Urology 83(6):1362-1368;
- Year
- 2014
- Research Committee(s)
- Cancer Control
- PMID
- PMID24862395
- PMC
- PMC4035700
- Study Number(s)
- SWOG-9217
Prostate Cancer Prevention Trial risk calculator 2.0: for the prediction of low- vs high-grade prostate cancer
- Journal / Conference
- Journal of the National Cancer Institute Sep 10;106(9): pii: dju240. Print 2014 Sep.;
- Year
- 2014
- Research Committee(s)
- Cancer Control, Prevention, Screening, and and Surveillance
- PMID
- PMID2521020
- PMC
- PMC4188122
- Study Number(s)
- S0000, SWOG-9217
Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies
- Journal / Conference
- Cancer Survivorship Research Conference (June 18-20, 2014 Atlanta, GA), poster;
- Year
- 2014
- Research Committee(s)
- Cancer Survivorship
Meeting cancer survivors needs: survivors perspective
- Journal / Conference
- Cancer Survivorship Research Conference (June 18-20, 2014 Atlanta, GA), poster;
- Year
- 2014
- Research Committee(s)
- Cancer Survivorship
Results of a survivorship needs assessment survey within a large cooperative group (SWOG)
- Journal / Conference
- Journal of Clinical Oncology 32:5s (suppl; abstr 10508);ASCO Annual Meeting (May 30-June 3, 2014, Chicago, IL), oral;
- Year
- 2014
- Research Committee(s)
- Sarcoma
- Study Number(s)
- S0033
Long-term disease control of advanced gastrointestinal stromal tumors (GIST) with imatinib (IM): 10-year outcomes from SWOG phase III intergroup trial S0033
- Journal / Conference
- Journal of Clinical Oncology 32:5s (suppl; abstr 1016); ASCO Annual Meeting (May 30-June 3, 2014, Chicago, IL), poster highlights session;
- Year
- 2014
- Research Committee(s)
- Breast
- Study Number(s)
- S0221
Outcome of male patients and black patients enrolled in SWOG S0221, an intergroup chemotherapy study
- Journal / Conference
- Journal of Clinical Oncology 32:5s (suppl; abstr LBA505); ASCO Annual Meeting (May 30-June 3, 2014, Chicago, IL), oral;
- Year
- 2014
- Research Committee(s)
- Breast
- Study Number(s)
- S0230
Phase III Trial (Prevention of Early Menopause Study [POEMS]-SWOG S0230) of LHRH Analog during Chemotherapy to Reduce Ovarian Failure in Early Stage, Hormone-Receptor Negative Breast Cancer: An International Intergroup Trial of SWOG, IBCSG, ECOG, CALGB (Alliance)
- Journal / Conference
- Journal of Clinical Oncology 32:5s (suppl; abstr 558); ASCO Annual Meeting (May 30-June 3, 2014, Chicago, IL), general poster session;
- Year
- 2014
- Research Committee(s)
- Breast
- Study Number(s)
- S0307
SWOG S0307 phase III trial of bisphosphonates as adjuvant therapy in primary breast cancer: Comparison of toxicities and patient-stated preference for oral versus intravenous delivery (ClinicalTrials.gov Identifier: NCT00127205)
- Journal / Conference
- Journal of Clinical Oncology 32:5s (suppl; abstr 4030);ASCO Annual Meeting (May 30-June 3, 2014, Chicago, IL), poster highlights session;
- Year
- 2014
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0809